Gene · 3587
Papers3,503
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,503
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metastasis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma. | Aging (Albany NY) | 2023 | 37494671 | PubTator, text mining | PubMed |
| The double-edged role of neutrophil heterogeneity in inflammatory diseases and cancers. | MedComm (2020) | 2023 | 37492784 | PubTator, text mining | PubMed |
| Neuroprotective effects of interleukin 10 in spinal cord injury. | Front Mol Neurosci | 2023 | 37492521 | PubTator, text mining | PubMed |
| Inborn errors of immunity in mainland China: the past, present and future. | BMJ Paediatr Open | 2023 | 37474202 | PubTator, text mining | PubMed |
| Propensity score analysis the clinical characteristics of active distal and extensive ulcerative colitis: a retrospective study. | Front Physiol | 2023 | 37457023 | PubTator, text mining | PubMed |
| Interleukin-10 enhances activity of ventral tegmental area dopamine neurons resulting in increased dopamine release. | Brain Behav Immun | 2023 | 37453452 | PubTator, text mining | PubMed |
| Anti-Inflammatory Effect and Signaling Mechanism of Glycine max Hydrolyzed with Enzymes from Bacillus velezensis KMU01 in a Dextran-Sulfate-Sodium-Induced Colitis Mouse Model. | Nutrients | 2023 | 37447355 | PubTator, text mining | PubMed |
| Expression of the readthrough transcript CiDRE in alveolar macrophages boosts SARS-CoV-2 susceptibility and promotes COVID-19 severity. | Immunity | 2023 | 37442134 | PubTator, text mining | PubMed |
| Differential expression profile of genes involved in the immune response associated to progression of chronic Chagas disease. | PLoS Negl Trop Dis | 2023 | 37440604 | PubTator, text mining | PubMed |
| Psoriasis Associated Hub Genes Revealed by Weighted Gene Co-Expression Network Analysis. | Cell J | 2023 | 37434459 | PubTator, text mining | PubMed |
| Spatially resolved transcriptomic profiles reveal unique defining molecular features of infiltrative 5ALA-metabolizing cells associated with glioblastoma recurrence. | Genome Med | 2023 | 37434262 | PubTator, text mining | PubMed |
| Linker histone variant H1.2 is a brake on white adipose tissue browning. | Nat Commun | 2023 | 37414781 | PubTator, text mining | PubMed |
| Implication of the Transmembrane Domain in the Interleukin 10 Receptor Platform Oligomerisation. | Cells | 2023 | 37408195 | PubTator, text mining | PubMed |
| Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I-III lung adenocarcinoma. | Genes Dis | 2023 | 37397559 | PubTator, text mining | PubMed |
| An interleukin 10 Receptor alpha (IL-10RA) variant with a compound heterozygote mutation shows normal IL-10 signaling activity. | Genes Dis | 2023 | 37396537 | PubTator, text mining | PubMed |
| Differentiation of IL-26+ TH17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis. | Nat Commun | 2023 | 37391412 | PubTator, text mining | PubMed |
| The spectrum of clinical presentation in haploinsufficiency of A20; a case report of a novel mutation in TNFAIP3 gene. | Front Pediatr | 2023 | 37388287 | PubTator, text mining | PubMed |
| Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition. | Sci Adv | 2023 | 37379383 | PubTator, text mining | PubMed |
| Intrinsic Effects of Exposome in Atopic Dermatitis: Genomics, Epigenomics and Regulatory Layers. | J Clin Med | 2023 | 37373692 | PubTator, text mining | PubMed |
| Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers. | Int J Mol Sci | 2023 | 37373521 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3587/papers?page=17